Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.

Hamidovic A, Dlugos A, Palmer AA, de Wit H.

Behav Genet. 2010 Mar;40(2):255-61. doi: 10.1007/s10519-009-9331-7. Epub 2010 Jan 21.

2.

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.

Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1129-1139.e2. doi: 10.1016/j.jaac.2011.08.002. Epub 2011 Sep 15.

3.

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):233-9. doi: 10.1089/cap.2008.0133.

4.

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA.

J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1155-64. doi: 10.1097/CHI.0b013e3181bc72e3.

5.

Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.

Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD, Batchelder H, Clarke A, Fischman AJ.

Biol Psychiatry. 2013 Jul 15;74(2):84-9. doi: 10.1016/j.biopsych.2012.11.010. Epub 2012 Dec 27.

6.

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):201-8.

PMID:
17955457
7.

Norepinephrine transporter gene variation modulates acute response to D-amphetamine.

Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, de Wit H.

Biol Psychiatry. 2007 Jun 1;61(11):1296-305. Epub 2007 Jan 17.

PMID:
17239355
8.

Dopamine transporter gene associated with diminished subjective response to amphetamine.

Lott DC, Kim SJ, Cook EH Jr, de Wit H.

Neuropsychopharmacology. 2005 Mar;30(3):602-9.

9.
10.
11.

Serotonin transporter genotype and acute subjective response to amphetamine.

Lott DC, Kim SJ, Cook EH, de Wit H.

Am J Addict. 2006 Sep-Oct;15(5):327-35.

PMID:
16966188
12.

Dopamine transporter genotype influences the physiological response to medication in ADHD.

Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM.

Brain. 2006 Aug;129(Pt 8):2038-46. Epub 2006 Jun 7.

PMID:
16760197
13.

Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.

Hamidovic A, Childs E, Conrad M, King A, de Wit H.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):175-80. doi: 10.1016/j.drugalcdep.2009.12.029. Epub 2010 Feb 21.

14.

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

Purper-Ouakil D, Wohl M, Orejarena S, Cortese S, Boni C, Asch M, Mouren MC, Gorwood P.

Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1425-30. doi: 10.1002/ajmg.b.30809.

PMID:
18563707
15.

Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.

Leddy JJ, Waxmonsky JG, Salis RJ, Paluch RA, Gnagy EM, Mahaney P, Erbe R, Pelham WE, Epstein LH.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):127-36. doi: 10.1089/cap.2008.046.

PMID:
19364291
16.

Further evidence of association between amphetamine response and SLC6A2 gene variants.

Dlugos AM, Hamidovic A, Palmer AA, de Wit H.

Psychopharmacology (Berl). 2009 Oct;206(3):501-11. doi: 10.1007/s00213-009-1628-y.

17.

Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.

Dresler T, Ehlis AC, Heinzel S, Renner TJ, Reif A, Baehne CG, Heine M, Boreatti-Hümmer A, Jacob CP, Lesch KP, Fallgatter AJ.

Neuropsychopharmacology. 2010 Oct;35(11):2193-202. doi: 10.1038/npp.2010.91. Epub 2010 Jul 14.

18.

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Froehlich TE, McGough JJ, Stein MA.

CNS Drugs. 2010 Feb;24(2):99-117. doi: 10.2165/11530290-000000000-00000. Review.

19.

OPRM1 gene variants modulate amphetamine-induced euphoria in humans.

Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA, de Wit H.

Genes Brain Behav. 2011 Mar;10(2):199-209. doi: 10.1111/j.1601-183X.2010.00655.x. Epub 2010 Nov 2.

20.

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

Kambeitz J, Romanos M, Ettinger U.

Pharmacogenomics J. 2014 Feb;14(1):77-84. doi: 10.1038/tpj.2013.9. Epub 2013 Apr 16.

PMID:
23588108

Supplemental Content

Support Center